Osheru
Osheru is a Bend, Oregon-based private medical device company that develops the FDA Class I Ziplyft device, using its patented Compression Skin Contouring (CoCo) platform to enable sutureless, bloodless, in-office upper eyelid lifts for ophthalmologists, oculoplastic surgeons, and aesthetic practitioners.
- Company typePrivate
- Founded2021
- HeadquartersBend, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Osheru does
Osheru is a Bend, Oregon-based private medical device company founded in 2020/2021 by Drs. Patty and Knute Buehler. The company develops and commercializes the Ziplyft device, an FDA Class I, 510(k) exempt medical device that uses the proprietary Compression Skin Contouring (CoCo) platform technology to enable sutureless, bloodless upper eyelid lifts (blepharoplasty). The device applies controlled tissue compression to achieve hemostasis and fuse tissue edges so that a guarded blade can excise redundant skin and closure can be achieved with medical adhesive rather than sutures, cautery, or IV sedation. Procedures are performed in-office under local anesthesia in approximately 10 minutes, with recovery reported in 5-7 days versus 2-3 weeks for traditional blepharoplasty.
The product portfolio is centered on Ziplyft and the underlying CoCo platform, with stated extensibility to lower lids, brow, chin, neck, and broader facial contouring. Osheru has built a medical advisory board of five key opinion leaders and, as of 2026, reports more than 142 procedures performed across 8 surgeons in clinical and early-adoption settings. The company has secured multiple industry recognitions including the 2022 Bend Venture Conference early-stage award and back-to-back Eyecelerator wins at ASCRS in 2023 and 2024.
Osheru generates revenue primarily through direct hardware sales of Ziplyft device and procedure kits to certified ophthalmologists, oculoplastic surgeons, and aesthetic practitioners via its e-commerce platform (products.ziplyft.com), supplemented by practitioner certification and training revenue. Pricing is described as comparable to traditional blepharoplasty but is quote-based and not publicly disclosed. Distribution is direct-to-surgeon, US-and-Canada focused, with a Medical Advisory Board functioning as the primary peer-referral channel. Capital to date totals approximately $4.95M, comprising a $4.7M seed round in July 2024 led by Nike co-founder Phil Knight with participation from Business Oregon, SOPHINCAP, and other family offices, plus a $250,000 SSBCI-backed investment from Elevate Capital in January 2026.
Osheru firmographics
Firmographics- Name
- Osheru
- Legal name
- Osheru LLC
- Website
- https://ziplyft.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Osheru is a Bend, Oregon-based private medical device company that develops the FDA Class I Ziplyft device, using its patented Compression Skin Contouring (CoCo) platform to enable sutureless, bloodless, in-office upper eyelid lifts for ophthalmologists, oculoplastic surgeons, and aesthetic practitioners.
- Ownership category
- akta.pro rank
Osheru industry classification
Industry- Product category
- Ophthalmic Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
- akta.pro primary industry
- Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL)
Keywords
Where Osheru is headquartered
LocationHeadquarters
- HQ city
- Bend
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Osheru business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Ziplyft Device and Kit Sales: Sale of medical devices and clinical procedure kits to certified ophthalmologists, oculoplastic surgeons, and aesthetic practitioners for in-office blepharoplasty procedures. Kits include all necessary procedural tools including the Ziplyft clamp device and medical adhesive.
- Practitioner Certification and Training: Revenue from training programs, certification modules, and ongoing professional support for practitioners adopting CoCo and Ziplyft procedures. Training includes video instruction, hands-on practice, and ongoing support.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Osheru product offering
Product offeringCore offering
Osheru manufactures and sells the Ziplyft device, an FDA Class I, 510(k) exempt medical instrument that uses its patented Compression Skin Contouring (CoCo) technology to perform bloodless, sutureless upper eyelid lifts in-office under local anesthesia in approximately 10 minutes. The company ships Ziplyft kits directly to certified ophthalmologists and oculoplastic surgeons and pairs device sales with mandatory practitioner certification and clinical training programs.
Product overview
Osheru is a medical device company with a unified product portfolio centered on its Ziplyft device and the proprietary Compression Skin Contouring (CoCo) technology platform. Ziplyft is an FDA Class I, 510(k) exempt medical device for upper eyelid rejuvenation using blepharoplasty; it is the first compression skin contouring (CoCo) device enabling sutureless, bloodless eyelid lifts performed in-office under local anesthesia in approximately 10 minutes. CoCo serves as the core technology platform, with extensibility planned for lower lids, brow, chin, neck, and facial contouring applications.
Differentiator
Problem solved
Functional benefit
Brands
- Ziplyft™: FDA Class I medical device for compression skin contouring (CoCo) enabling sutureless, bloodless upper eyelid lifts. First-in-class blepharoplasty device.
- CoCo (Compression Skin Contouring)
- MILT (Minimally Invasive Lid Treatment)
Products and services
- Ziplyft Device FDA Class I, 510(k) exempt medical device that uses Compression Skin Contouring (CoCo) technology to perform bloodless, sutureless upper eyelid lifts in-office under local anesthesia in approximately 10 minutes. Sold as a device kit to certified ophthalmologists and oculoplastic surgeons for cosmetic and functional blepharoplasty procedures.
- Practitioner Certification and Training Program Required certification, video instruction, hands-on practice, and ongoing support program that surgeons must complete before purchasing Ziplyft device kits. Includes clinical training on the CoCo and MILT procedural methods for upper eyelid lifts.
Quantifiable outcome
- 142+ patients treated with Ziplyft as of 2026
- +5 more outcomes
Companies that use Osheru
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
Osheru technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Osheru partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
Osheru competitors and assessment
Company assessmentBroad incumbents
- Lumenis: Lumenis is a global leader in energy-based medical and aesthetic devices, with strong ophthalmic and aesthetic surgery franchises. Comparable to Osheru as a broader incumbent operating in overlapping ophthalmic/aesthetic device categories that could expand into compression or mechanical blepharoplasty solutions.
- Cynosure: Cynosure develops laser, light-based, and energy-based aesthetic platforms sold to plastic surgeons, dermatologists, and aesthetic practices. Comparable to Osheru as a larger incumbent addressing the same physician customer base seeking high-throughput in-office aesthetic procedures.
- Alma Lasers: Alma Lasers is a global provider of aesthetic and surgical laser, light, RF, and ultrasound platforms for the medical aesthetics market. Comparable to Osheru as a broader incumbent offering multiple in-office aesthetic device solutions that compete for the same physician capital expenditure budgets.
- Alcon: Alcon is one of the largest global ophthalmic device and surgical companies, with deep relationships among cataract, refractive, and oculoplastic surgeons. Comparable to Osheru as a broad ophthalmic incumbent whose surgeon customer base is identical to Ziplyft's and who could launch competing eyelid surgery devices.
- Cutera: Cutera manufactures laser and energy-based aesthetic systems for face and body treatments sold through medical aesthetic channels. Comparable to Osheru as an established aesthetics-device incumbent whose customer base (aesthetic physicians and practices) overlaps with Ziplyft's target surgeon population.
- Bausch + Lomb: Bausch + Lomb is a global ophthalmic company spanning surgical, vision care, and ophthalmic pharmaceuticals with extensive surgeon relationships. Comparable to Osheru as a broad incumbent in the ophthalmic surgical space that could leverage scale to compete in oculoplastic and eyelid surgery device categories.
Direct peers
- Sciton: Sciton manufactures laser and light-based aesthetic and surgical platforms used in facial rejuvenation procedures including around the eyes. Comparable to Osheru in its focus on physician-channel aesthetic devices that improve procedure efficiency and recovery for cosmetic surgeons.
- InMode: InMode develops minimally invasive aesthetic medical devices, including RF-based technologies applied to facial and periocular rejuvenation. Comparable to Osheru as a device-driven company targeting aesthetic surgeons and ophthalmologists seeking less invasive, in-office procedures.
- LightScalpel: LightScalpel makes a CO2 laser system specifically marketed for blepharoplasty and eyelid surgery in office-based settings. A direct procedural-area peer to Ziplyft as both target oculoplastic and ophthalmic surgeons performing eyelid lifts with technology designed to improve patient outcomes.
Emerging players
- Cytrellis Biosystems: Cytrellis is an early-stage aesthetics device company developing minimally invasive skin removal technologies for facial rejuvenation. Comparable to Osheru as a similarly staged emerging player pursuing novel, in-office aesthetic procedures targeting physician practices, with potential overlap in facial rejuvenation indications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Osheru social profiles
Digital presenceOsheru compliance and trust
Trust signalCompliance1 record
Osheru financial estimates
Financial estimateRevenue estimate
Valuation estimate
Osheru leadership team
Management profileNumber of profiles
Profiles3 records
Osheru funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Osheru M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Osheru
What does Osheru do?
Osheru manufactures and sells the Ziplyft device, an FDA Class I, 510(k) exempt medical instrument that uses its patented Compression Skin Contouring (CoCo) technology to perform bloodless, sutureless upper eyelid lifts in-office under local anesthesia in approximately 10 minutes. The company ships Ziplyft kits directly to certified ophthalmologists and oculoplastic surgeons and pairs device sales with mandatory practitioner certification and clinical training programs.
Is Osheru a public or private company?
Osheru is a private company. It is classified as venture growth investor backed and is currently operating.
When was Osheru founded?
Osheru was founded in 2021. It employs 11 to 50 people.
Where is Osheru based?
Osheru is headquartered in Bend, United States, in the North America region.
How does Osheru make money?
Two revenue lines are on record. Ziplyft Device and Kit Sales are the primary driver. The others are practitioner Certification and Training.
Who are Osheru's main competitors?
Broad incumbents on record are Lumenis, Cynosure, Alma Lasers, Alcon, Cutera and Bausch + Lomb. Direct peers are Sciton, InMode and LightScalpel. Cytrellis Biosystems is listed as an emerging player.
Does Osheru have an API?
No public API is recorded for Osheru.
What industry is Osheru in?
Osheru's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAL, Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants). Its NAICS code is 339112 and its SIC code is 3841.